share_log

HC Wainwright & Co. Maintains Buy on BioAtla, Lowers Price Target to $10

HC Wainwright & Co. Maintains Buy on BioAtla, Lowers Price Target to $10

HC Wainwright & Co.维持对BioAtla的买入,将目标价下调至10美元
Benzinga ·  2023/11/08 08:11

HC Wainwright & Co. analyst Arthur He maintains BioAtla (NASDAQ:BCAB) with a Buy and lowers the price target from $17 to $10.

HC Wainwright & Co. 分析师亚瑟·何维持BioAtla(纳斯达克股票代码:BCAB)的买入,并将目标股价从17美元下调至10美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发